Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2011
08/24/2011CN101810688B Chinese medicinal composition for treating urinary disease and preparation method thereof
08/24/2011CN101617727B Fig health-care tea leaf
08/24/2011CN101579313B Cefalexin liposome and medicinal composition thereof
08/24/2011CN101530486B Radix clematidis-ephedra traditional Chinese medicine preparation for treating urinary calculus, preparation method and quality testing method thereof
08/24/2011CN101327246B Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint
08/24/2011CN101288749B Medicine for treating renal calculus and its preparing process
08/24/2011CN101166706B Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
08/24/2011CN101015312B Health care functional tea for conditioning subhealthy state
08/24/2011CN100999519B (-) poly thaazoleazine methylsulfonate, its preparation process and use
08/23/2011US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
08/23/2011US8003347 Nucleic acids encoding ChemerinR ligands
08/23/2011CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011CA2377209C Therapeutic peptide-based constructs
08/18/2011WO2011099570A1 Age production inhibitor
08/18/2011WO2011098818A1 Dietary supplement composition
08/18/2011US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
08/18/2011US20110201616 Sulfonamide compounds or salts thereof
08/18/2011US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
08/18/2011US20110201601 Inhibitors of the shiga toxins trafficking through the retrograde pathway
08/18/2011US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011US20110201587 Hsp90 inhibitors and methods of use
08/17/2011EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011EP2357193A1 Human GIL-19/AE289 proteins and polynucleotides encoding same
08/17/2011EP2357008A1 Albumin fusion proteins
08/17/2011EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof
08/17/2011EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011EP2355850A2 N-cadherin: target for cancer diagnosis and therapy
08/17/2011EP2355839A2 Compositions and methods of use for soluble thrombomodulin variants
08/17/2011EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
08/17/2011EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011CN1943701B A kind of medicine for treatment of non-gonococcal urethritis(NGU) and its preparation method
08/17/2011CN1895598B Chinese-medicinal powder for nourishing kidney of fowl
08/17/2011CN1715926B Use of neuregulin mutant
08/17/2011CN102159582A Oxazolopyrimidines as edg-1 receptor agonists
08/17/2011CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors
08/17/2011CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
08/17/2011CN102153630A Ring octapeptide and preparation method and application thereof in medicament making
08/17/2011CN102153555A Carbapenem compound containing amido formacyl heterocycle
08/17/2011CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
08/17/2011CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/17/2011CN102153538A Benzocyclodirivative
08/17/2011CN102151305A Shinyleaf yellowhorn extractive, extraction method thereof and user thereof
08/17/2011CN102151284A Composition containing fucoidin sulfate and application thereof
08/17/2011CN102151262A Compounds for the treatment of metabolic disorders
08/17/2011CN101904991B Natural calculus-dissolving medicament
08/17/2011CN101850071B Chinese medicament for treating chronic nephritis
08/17/2011CN101843826B Chinese medicament for treating chronic kidney failure
08/17/2011CN101843818B Chinese medicament for treating chronic nephritis
08/17/2011CN101843756B Chinese medicament for treating chronic nephritis
08/17/2011CN101843699B Chinese medicament for treating benign prostatic hyperplasiabrain
08/17/2011CN101829182B Medicament for treating prostatic diseases
08/17/2011CN101732603B Chinese medicinal decoction for treating urinary stone disease
08/17/2011CN101703714B Chinese medicinal medicament for treating acute glomerulonephritis
08/17/2011CN101653533B Chinese medicament capable of treating appendicitis, cholecystitis, diseases of fallopian tubes and calculus diseases
08/17/2011CN101559216B Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof
08/17/2011CN101549049B Chinese medicinal combination for treating acute nephritis and chronic nephritis
08/17/2011CN101543523B Uyghur drug compound recipe extracting technology for chiccory
08/17/2011CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
08/17/2011CN101491593B Medicine for treating nephritis
08/17/2011CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination
08/17/2011CN101375987B Anti-inflammation formulation for treating chronic prostatitis and preparation method thereof
08/17/2011CN101011533B Chinese traditional medicine composition for treating kidney-yang deficiency and preparation and quality controlling method thereof
08/16/2011US7999109 CCR9 inhibitors and methods of use thereof
08/16/2011US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
08/16/2011US7998972 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
08/16/2011CA2487095C Elongase genes and uses thereof
08/12/2011DE202010007074U1 Neue Darreichungsformen für Cineol New forms of cineole
08/11/2011WO2011096490A1 Imidazopyridin-2-one derivative
08/11/2011WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/11/2011WO2011096377A1 Pyrrole compound
08/11/2011WO2011066006A3 Methods for treating aids
08/11/2011US20110196037 Use of nitrated lipids for treatment of side effects of toxic medical therapies
08/11/2011US20110196033 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
08/11/2011US20110196023 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
08/11/2011US20110196022 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
08/11/2011US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins
08/11/2011US20110195987 Treatment with cholinergic agonists
08/11/2011US20110195965 Tetrahydro- and dihydroquinazolinones
08/11/2011US20110195945 Compounds, Compositions and Methods for Treating or Preventing Hypoxic or Ischemic Injury
08/11/2011US20110195909 Novel x-conotoxin peptides (-ii)
08/11/2011US20110195904 Methods of treatment using exendin peptides or glp-1 peptides
08/11/2011US20110195903 Methods and compositions for detecting recessive familial fsgs and uses thereof
08/11/2011US20110195899 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid
08/11/2011US20110195077 Methods and compositions using fgf23 fusion ppolypeptides
08/11/2011US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS
08/11/2011US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
08/11/2011CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/10/2011EP2354163A2 Conjugates of duocarmycin and anti-CD70 or anti-PSMA antibodies
08/10/2011EP2354134A1 2h-chromene compound and derivative thereof
08/10/2011EP2352503A1 Role of soluble upar in the pathogenesis of proteinuric kidney disease
08/10/2011CN1931302B Chinese medicine composition for treating urethral calculus and gallstones and its prepn process
08/10/2011CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/10/2011CN102149712A Pyrazole [3, 4-b] pyridine Raf inhibitors
08/10/2011CN102149382A New therapeutic use of drotaverine
08/10/2011CN102146074A Preparation method of pyrrole derivative and application thereof
08/10/2011CN102145150A Medicine for treatment of uninary calculi
08/10/2011CN102145147A Medicated wine with functions of tonifying kidney and nourishing vitality
08/10/2011CN102145146A Method for detecting medicinal composition for treating urinary system diseases